Skip To Main Content
W. Carr on Muck Rack

W. Carr

As seen in: Annals of Allergy, Asthma & Immunology, Clearwater Tribune
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to W. Carr’s profile

Articles by W. Carr

NOTICE TO CREDITORS - HARGREAVES

|
By W. Carr
| Clearwater Tribune Verified
WILLIAM JEREMY CARR CLARK and FEENEY LLP 1229 Main Street P. O. Drawer 285 Lewiston, ID 83501 Telephone: (208) 743-9516 Facsimile: (208) 746-9160 Idaho State Bar #6827 Attorneys for Personal Representative darla@clarkandfeeney.com IN THE DISTRICT COURT OF THE SECOND JUDICIAL DISTRICT OF THE STATE OF IDAHO, IN AND FOR THE COUNTY OF CLEARWATER In the Matter of the Estate of: PHYLLIS HARGREAVES, Deceased.
Open in Who Shared Issue with article?

NOTICE TO CREDITORS - FRISBY, SR.

|
By W. Carr
| Clearwater Tribune Verified
WILLIAM JEREMY CARR CLARK and FEENEY LLP 1229 Main Street P. O. Drawer 285 Lewiston, ID 83501 Telephone: (208) 743-9516 Facsimile: (208) 746-9160 Idaho State Bar #6827 Attorneys for Personal Representative darla@clarkandfeeney.com IN THE DISTRICT COURT OF THE SECOND JUDICIAL DISTRICT OF THE STATE OF IDAHO, IN AND FOR THE COUNTY OF CLEARWATER In the Matter of the Estate of: GEORGE FRISBY, SR., Deceased. CASE NO.
Open in Who Shared Issue with article?

NOTICE TO CREDITORS - STANTON

|
By W. Carr
| Clearwater Tribune Verified
WILLIAM JEREMY CARR CLARK and FEENEY LLP 1229 Main Street P.O. Box 285 Lewiston, Idaho 83501 Telephone: (208) 743-9516 Facsimile: (208) 746-9160 Idaho State Bar #6827 Attorneys for Personal Representative darla@clarkandfeeney.com IN THE DISTRICT COURT OF THE SECOND JUDICIAL DISTRICT OF THE STATE OF IDAHO, IN AND FOR THE COUNTY OF CLEARWATER In the Matter of the Estate of: JAMES H. STANTON, JR. Deceased, CASE NO.
Open in Who Shared View Duplicates (2) Issue with article?

NOTICE TO CREDITORS--KOM

|
By W. Carr
| Clearwater Tribune Verified
WILLIAM JEREMY CARR CLARK and FEENEY LLP 1229 Main Street P.O. Box 285 Lewiston, Idaho 83501 Telephone: (208) 743-9516 Facsimile: (208) 746-9160 Idaho State Bar #6827 Attorneys for Personal Representative darla@clarkandfeeney.com IN THE DISTRICT COURT OF THE SECOND JUDICIAL DISTRICT OF THE STATE OF IDAHO, IN AND FOR THE COUNTY OF CLEARWATER In the Matter of the Estates of: BERNICE MAY KOM, Deceased, and HARVEY CLARENCE KOM, Deceased. CASE NO.
Open in Who Shared Issue with article?

P223 DUPILUMAB IMPROVED ASTHMA CONTROL ACROSS BASELINE IMMUNOGLOBULIN E LEVELS: LIBERTY ASTHMA QUEST STUDY

|
By W. Carr, Mission Viejo, J. Corren, M. B. Rice
| Annals of Allergy, Asthma & Immunology Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Dupilumab, a fully human monoclonal antibody, blocks the shared receptor component for interleukin (IL)-4/IL-13, key drivers of type 2 inflammation in multiple diseases.
Open in Who Shared Issue with article?

P303 SAFETY AND EFFICACY COMPARISON: ARTEMIS AND PALISADE PHASE 3 STUDIES OF AR101 IN PEANUT ALLERGY

|
By E. Sher, J. Hourihane, W. Carr, Mission Viejo
| Annals of Allergy, Asthma & Immunology Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. AR101, an investigational oral biologic drug for peanut oral immunotherapy, was studied in PALISADE and ARTEMIS phase 3 trials. Efficacy and safety results are compared.
Open in Who Shared Issue with article?

P321 HIGH DOSE PEANUT ORAL IMMUNOTHERAPY IN CLINICAL PRACTICE IS SAFE AND EFFECTIVE

|
By K. K. Nguyen, W. Carr
| Annals of Allergy, Asthma & Immunology Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Growing data supports peanut oral immunotherapy (POIT) as an effective therapy for the treatment of peanut allergy. Recent publications have raised concerns about the long-term safety of POIT. We report the safety, efficacy, and success rates for patients undergoing high dose POIT in an outpatient allergy clinic setting.
Open in Who Shared Issue with article?

Oklahoma State Medical Proceedings

|
By W. Carr, Yi-Chen Lin, Jennifer Volberding, Benjamin Timson
| okstatemedicalproceedings.com
Skip to main content Skip to main navigation menu Skip to site footer
Open in Who Shared Issue with article?

P223 Reslizumab improves spirometric lung age in patients with severe eosinophilic asthma

|
By Mission Viejo, M. McDonald, W. Carr, P. Meizlik
| Annals of Allergy, Asthma & Immunology Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Spirometric 'lung age' is the estimation of age based on FEV1 as compared to a normal person with the same FEV1, and has been used as a patient education tool.
Open in Who Shared Issue with article?
Show More